ArticleCell cycle (Georgetown, Tex.)2024

Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks.

Jiajun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.